Recent Progress in Herpes Simplex Virus Immunobiology and Vaccine Research

Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway

Hemmi, H., Kaisho, T., Takeuchi, O., Sato, S., Sanjo, H., Hoshino, K., Horiuchi, T., Tomizawa, H., Takeda, K., & Akira, S. (2002) · Nature Immunology · doi:10.1038/ni758 · Cited by 2,517 · see citing works

The Nature of the Principal Type 1 Interferon-Producing Cells in Human Blood

Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S., & Liu, Y.-J. (1999) · Science · doi:10.1126/science.284.5421.1835 · Cited by 2,293 · see citing works

The Complete DNA Sequence of the Long Unique Region in the Genome of Herpes Simplex Virus Type 1

McGeoch, D. J., Dalrymple, M. A., Davison, A. J., Dolan, A., Frame, M. C., McNab, D., Perry, L. J., Scott, J. E., & Taylor, P. (1988) · Journal of General Virology · doi:10.1099/0022-1317-69-7-1531 · Cited by 1,618 · see citing works

Herpes Simplex Viruses

Whitley, R. J., Kimberlin, D. W., & Roizman, B. (1998) · Clinical Infectious Diseases · doi:10.1086/514600 · Cited by 1,151 · see citing works

Herpes Simplex Virus-1 Entry into Cells Mediated by a Novel Member of the TNF/NGF Receptor Family

Montgomery, R. I., Warner, M. S., Lum, B. J., & Spear, P. G. (1996) · Cell · doi:10.1016/s0092-8674(00)81363-x · Cited by 1,099 · see citing works

Dendritic Cell Subsets and Lineages, and Their Functions in Innate and Adaptive Immunity

Liu, Y.-J. (2001) · Cell · doi:10.1016/s0092-8674(01)00456-1 · Cited by 1,006 · see citing works

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

Markert, J. M., Medlock, M. D., Rabkin, S. D., Gillespie, G. Y., Todo, T., Hunter, W. D. G., Palmer, C. A., Feigenbaum, F., Tornatore, C., Tufaro, F., et al. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301205 · Cited by 976 · see citing works

Genital Herpes Simplex Virus Infections: Clinical Manifestations, Course, and Complications

Corey, L., ADAMS, H. G., BROWN, Z. A., & HOLMES, K. K. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-6-958 · Cited by 928 · see citing works

Viral Subversion of the Immune System

Tortorella, D., Gewurz, B. E., Furman, M. H., Schust, D. J., & Ploegh, H. L. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.861 · Cited by 828 · see citing works

Herpes simplex virus turns off the TAP to evade host immunity

Hill, A. B., Jugovic, P., York, L., Russ, G., Bennink, J., Yewdell, J. W., Ploegh, H. L., & Johnson, D. C. (1995) · Nature · doi:10.1038/375411a0 · Cited by 802 · see citing works

Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes

Stanberry, L. R., Spruance, S. L., Cunningham, A. L., Bernstein, D. I., Mindel, A., Sacks, S. L., Tyring, S. K., Aoki, F. Y., Slaoui, M., Denis, M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011915 · Cited by 791 · see citing works

The Acquisition of Herpes Simplex Virus during Pregnancy

Brown, Z. A., Selke, S., Zeh, J., Kopelman, J. N., Maslow, A. S., Ashley, R. L., Watts, D. H., Berry, S., Herd, M., & Corey, L. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708213370801 · Cited by 778 · see citing works

Selective Expression of an Interleukin-12 Receptor Component by Human T Helper 1 Cells

Rogge, L., Barberis-Maino, L., Biffi, M., Passini, N., Presky, D. H., Gubler, U., & Sinigaglia, F. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.5.825 · Cited by 766 · see citing works

Type I Interferons Keep Activated T Cells Alive

Marrack, P., Kappler, J. W., & Mitchell, T. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.521 · Cited by 763 · see citing works

LIGHT, a New Member of the TNF Superfamily, and Lymphotoxin α Are Ligands for Herpesvirus Entry Mediator

Mauri, D. N., Ebner, R., Montgomery, R. I., Kochel, K. D., Cheung, T. C., Yu, G.-L., Ruben, S. M., Murphy, M., Eisenberg, R. J., Cohen, G. H., et al. (1998) · Immunity · doi:10.1016/s1074-7613(00)80455-0 · Cited by 757 · see citing works

Herpes simplex virus turns off the TAP to evade host immunity

(1995) · Trends in Genetics · doi:10.1016/0168-9525(95)90181-7 · Cited by 736 · see citing works

Mapping of Herpes Simplex Virus-1 Neurovirulence to γ 1 34.5, a Gene Nonessential for Growth in Culture

Chou, J., Kern, E. R., Whitley, R. J., & Roizman, B. (1990) · Science · doi:10.1126/science.2173860 · Cited by 711 · see citing works

Herpes Simplex Viruses

Whitley, R. J., & Roizman, B. (2002) · Wiley eBooks · doi:10.1002/0471203076.emm0597 · Cited by 701 · see citing works

Herpes simplex virus type 1 in brain and risk of Alzheimer's disease

Itzhaki, R. F., Lin, W., Shang, D., Wilcock, G. K., Faragher, B. E., & Jamieson, G. A. (1997) · The Lancet · doi:10.1016/s0140-6736(96)10149-5 · Cited by 671 · see citing works

Replication of hepatitis C virus

Bartenschlager, R. F. W., & Lohmann, V. (2000) · Microbiology · doi:10.1099/0022-1317-81-7-1631 · Cited by 612 · see citing works

A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes

York, I. A., Roop, C., Andrews, D. W., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90215-1 · Cited by 565 · see citing works

T–cell mediated rejection of gene–modified HIV–specific cytotoxic T lymphocytes in HIV–infected patients

Riddell, S. R., Elliott, M., Lewinsohn, D. A., Gilbert, M. J., Wilson, L., Manley, S. A., Lupton, S. D., Overell, R. W., Reynolds, T. C., Corey, L., et al. (1996) · Nature Medicine · doi:10.1038/nm0296-216 · Cited by 564 · see citing works

Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera

Ashley, R. L., Militoni, J., Lee, F., Nahmias, A. J., & Corey, L. (1988) · Journal of Clinical Microbiology · doi:10.1128/jcm.26.4.662-667.1988 · Cited by 539 · see citing works

Three Classes of Cell Surface Receptors for Alphaherpesvirus Entry

Spear, P. G., Eisenberg, R. J., & Cohen, G. H. (2000) · Virology · doi:10.1006/viro.2000.0529 · Cited by 523 · see citing works

A Prospective Study of New Infections with Herpes Simplex Virus Type 1 and Type 2

Langenberg, A. G. M., Corey, L., Ashley, R. L., Leong, W. P., & Straus, S. E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911043411904 · Cited by 508 · see citing works

Virologic Characteristics of Subclinical and Symptomatic Genital Herpes Infections

Wald, A., Zeh, J. E., Selke, S., Ashley, R. L., & Corey, L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509213331205 · Cited by 504 · see citing works

Molecular Mimicry by Herpes Simplex Virus-Type 1: Autoimmune Disease After Viral Infection

Zhao, Z.-S., Granucci, F., Yeh, L., Schaffer, P. A., & Cantor, H. (1998) · Science · doi:10.1126/science.279.5355.1344 · Cited by 503 · see citing works

Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry

Shukla, D., & Spear, P. G. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13799 · Cited by 497 · see citing works

Recombinant Glycoprotein Vaccine for the Prevention of Genital HSV-2 Infection

Corey, L., Langenberg, A. G. M., Ashley, R. L., Sekulovich, R. E., Izu, A., Douglas, J. M., Handsfield, H. H., Warren, T. J., Marr, L., Tyring, S. K., et al. (1999) · JAMA · doi:10.1001/jama.282.4.331 · Cited by 490 · see citing works

Risk Factors for the Sexual Transmission of Genital Herpes

MERTZ, G. J., Benedetti, J., Ashley, R. L., Selke, S., & Corey, L. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-3-197 · Cited by 473 · see citing works

Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor.

Brown, Z. A., Benedetti, J., Ashley, R., Burchett, S., Selke, S., Berry, S., Vontver, L. A., & Corey, L. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105023241804 · Cited by 473 · see citing works

Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry

Shukla, D., & Spear, P. G. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113799 · Cited by 454 · see citing works

Vaccine design : the subunit and adjuvant approach

Powell, M. F., Newman, M. J., & Burdman, J. R. (1995) · Plenum Press eBooks · Cited by 451 · see citing works

Recurrence Rates in Genital Herpes after Symptomatic First-Episode Infection

Benedetti, J., Corey, L., & Ashley, R. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-11-199412010-00004 · Cited by 425 · see citing works

Herpes Simplex Virus Glycoprotein D Bound to the Human Receptor HveA

Carfı́, A., Willis, S. H., Whitbeck, J. C., Krummenacher, C., Cohen, G. H., Eisenberg, R. J., & Wiley, D. C. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00298-2 · Cited by 391 · see citing works

Construction and properties of a mutant of herpes simplex virus type 1 with glycoprotein H coding sequences deleted

Forrester, A., Farrell, H. E., Wilkinson, G. W. G., Kaye, J. F., Davis-Poynter, N. J., & Minson, T. (1992) · Journal of Virology · doi:10.1128/jvi.66.1.341-348.1992 · Cited by 389 · see citing works

Cd8+ T Cells Can Block Herpes Simplex Virus Type 1 (HSV-1) Reactivation from Latency in Sensory Neurons

Liu, T., Khanna, K. M., Chen, X., Fink, D. J., & Hendricks, R. L. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.9.1459 · Cited by 385 · see citing works

The skin immune system: progress in cutaneous biology

Bos, J. D., & Kapsenberg, M. L. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90062-p · Cited by 385 · see citing works

HIV-1-Specific Mucosal CD8+ Lymphocyte Responses in the Cervix of HIV-1-Resistant Prostitutes in Nairobi

Kaul, R., Plummer, F. A., Kimani, J., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.3.1602 · Cited by 385 · see citing works

Viral mechanisms of immune evasion

Alcamı́, A., Alcamı́, A., & Koszinowski, U. H. (2000) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01830-8 · Cited by 363 · see citing works

The Genome Sequence of Herpes Simplex Virus Type 2

Dolan, A., Jamieson, F. E., Cunningham, C., Barnett, B. C., & McGeoch, D. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2010-2021.1998 · Cited by 355 · see citing works

Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes

Klenerman, P., & Zinkernagel, R. M. (1998) · Nature · doi:10.1038/28860 · Cited by 349 · see citing works

Mutations of PVRL1, encoding a cell-cell adhesion molecule/herpesvirus receptor, in cleft lip/palate-ectodermal dysplasia

Suzuki, K., Hu, D. P., Bustos, T., Zlotogora, J., Richieri‐Costa, A., Helms, J. A., & Spritz, R. A. (2000) · Nature Genetics · doi:10.1038/78119 · Cited by 332 · see citing works

Complete DNA sequence of the short repeat region in the genome of herpes simplex virus type 1

McGeoch, D. J., Dolan, A., Donald, S., & Brauer, D. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.4.1727 · Cited by 332 · see citing works

"Tolerosomes" are produced by intestinal epithelial cells

Karlsson, M., Lundin, S. B., Dahlgren, U. I., Kahu, H., Pettersson, I., & Telemo, E. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(2001010)31:10 · Cited by 303 · see citing works

A Newly Identified Member of the Tumor Necrosis Factor Receptor Superfamily with a Wide Tissue Distribution and Involvement in Lymphocyte Activation

Kwon, B. S., Tan, K. B., Ni, J., Lee, Z. H., Kim, K. K., Kim, Y.-J., Wang, S., Gentz, R., Yu, G., Harrop, J., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.22.14272 · Cited by 300 · see citing works

MF59 Design and Evaluation of a Safe and Potent Adjuvant for Human Vaccines

Ott, G. S., Barchfeld, G. L., Chernoff, D., Radhakrishnan, R., van Hoogevest, P., & Nest, G. V. (1995) · Pharmaceutical biotechnology · doi:10.1007/978-1-4615-1823-5_10 · Cited by 298 · see citing works

Herpesvirus Entry Mediator, a Member of the Tumor Necrosis Factor Receptor (TNFR) Family, Interacts with Members of the TNFR-associated Factor Family and Activates the Transcription Factors NF-κB and AP-1

Marsters, S. A., Ayres, T. M., Skubatch, M., Gray, C. L., Rothe, M., & Ashkenazi, A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.22.14029 · Cited by 295 · see citing works

Mature Dendritic Cells Infected with Herpes Simplex Virus Type 1 Exhibit Inhibited T-Cell Stimulatory Capacity

Kruse, M., Rosorius, O., Krätzer, F., et al. (2000) · Journal of Virology · doi:10.1128/jvi.74.15.7127-7136.2000 · Cited by 280 · see citing works

Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes.

Koelle, D. M., Posavad, C. M., Barnum, G., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1758 · Cited by 264 · see citing works

Frequency of Acquisition of First-episode Genital Infection with Herpes Simplex Virus from Symptomatic and Asymptomatic Source Contacts

MERTS, G. J., Schmidt, O. W., Jourden, J., Guinan, M. E., Remington, M. L., FAHBLANDER, A., Winter, C., Holmes, K. K., & Corey, L. (1985) · Sexually Transmitted Diseases · doi:10.1097/00007435-198501000-00007 · Cited by 255 · see citing works

A Subunit Cytomegalovirus Vaccine Based on Recombinant Envelope Glycoprotein B and a New Adjuvant

Pass, R. F., Duliège, A., Boppana, S. B., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/315022 · Cited by 250 · see citing works

In Vivo Behavior of Genetically Engineered Herpes Simplex Viruses R7017 and R7020: Construction and Evaluation in Rodents

Meignier, B., Longnecker, R., & Roizman, B. (1988) · The Journal of Infectious Diseases · doi:10.1093/infdis/158.3.602 · Cited by 249 · see citing works

Gamma Interferon Can Prevent Herpes Simplex Virus Type 1 Reactivation from Latency in Sensory Neurons

Liu, T., Khanna, K. M., Carriere, B. N., & Hendricks, R. L. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.11178-11184.2001 · Cited by 243 · see citing works

Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons.

Simmons, A., & Tscharke, D. C. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.175.5.1337 · Cited by 240 · see citing works

Evolution of recurrent herpes simplex lesions. An immunohistologic study.

Cunningham, A. L., Turner, R. R., Miller, A. C., Para, M. F., & Merigan, T. C. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111678 · Cited by 239 · see citing works

Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration

Highlander, S. L., Sutherland, S., Gage, P. J., Johnson, D. C., Levine, M., & Glorioso, J. C. (1987) · Journal of Virology · doi:10.1128/jvi.61.11.3356-3364.1987 · Cited by 237 · see citing works

Immunity causing blindness: five different paths to herpes stromal keratitis

Streilein, J. W., Dana, M. R., & Ksander, B. R. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01114-6 · Cited by 234 · see citing works

Constitutive Expression of LIGHT on T Cells Leads to Lymphocyte Activation, Inflammation, and Tissue Destruction

Shaikh, R. B., Santee, S. M., Granger, S. W., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6330 · Cited by 234 · see citing works

Quantification of transcripts from the ICP4 and thymidine kinase genes in mouse ganglia latently infected with herpes simplex virus

Kramer, M. F., & Coen, D. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.3.1389-1399.1995 · Cited by 232 · see citing works

Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene

Leib, D. A., Machalek, M. A., Williams, B. R. G., Silverman, R. H., & Virgin, H. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100415697 · Cited by 230 · see citing works

Intranasal Immunization with CpG Oligodeoxynucleotides as an Adjuvant Dramatically Increases IgA and Protection Against Herpes Simplex Virus-2 in the Genital Tract

Gallichan, W. S., Woolstencroft, R. N., Guarasci, T., McCluskie, M. J., Davis, H. L., & Rosenthal, K. L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.5.3451 · Cited by 220 · see citing works

Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization

Kuklin, N. A., Daheshia, M., Karem, K. L., et al. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.3138-3145.1997 · Cited by 208 · see citing works

Asymptomatic Reactivation of Herpes Simplex Virus in Women after the First Episode of Genital Herpes

Koelle, D. M., Benedetti, J., Langenberg, A. G. M., et al. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-6-433 · Cited by 207 · see citing works

Infected Cell Protein (ICP)47 Enhances Herpes Simplex Virus Neurovirulence by Blocking the CD8+ T Cell Response

Goldsmith, K., Chen, W., Johnson, D. C., & Hendricks, R. L. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.3.341 · Cited by 206 · see citing works

Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes

Straus, S. E., Savarese, B., Krause, P. R., Kost, R. G., Meier, J. L., Corey, L., Barnum, G., Burke, R. L., Sekulovich, R. E., Adair, S. F., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92581-x · Cited by 203 · see citing works

Neutralizing antibodies specific for glycoprotein H of herpes simplex virus permit viral attachment to cells but prevent penetration

Fuller, A. O., Santos, R. E., & Spear, P. G. (1989) · Journal of Virology · doi:10.1128/jvi.63.8.3435-3443.1989 · Cited by 200 · see citing works

Prospects for Control of Herpes Simplex Virus Disease through Immunization

Stanberry, L. R., Cunningham, A. L., Mindel, A., Scott, L. L., Spruance, S. L., Aoki, F. Y., & Lacey, C. J. (2000) · Clinical Infectious Diseases · doi:10.1086/313687 · Cited by 200 · see citing works

Frequencies of Memory T Cells Specific for Varicella‐Zoster Virus, Herpes Simplex Virus, and Cytomegalovirus by Intracellular Detection of Cytokine Expression

Asanuma, H., Sharp, M., Maecker, H. T., Maino, V. C., & Arvin, A. M. (2000) · The Journal of Infectious Diseases · doi:10.1086/315347 · Cited by 199 · see citing works

IL-12 Gene as a DNA Vaccine Adjuvant in a Herpes Mouse Model: IL-12 Enhances Th1-Type CD4+ T Cell-Mediated Protective Immunity Against Herpes Simplex Virus-2 Challenge

Sin, J., Kim, J. J., Arnold, R. L., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.5.2912 · Cited by 197 · see citing works

Detection of Herpes Simplex Virus DNA in Cutaneous Lesions of Erythema Multiforme

Brice, S. L., Krzemien, D., Weston, W. L., et al. (1989) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12277397 · Cited by 193 · see citing works

T Lymphocytes Are Required for Protection of the Vaginal Mucosae and Sensory Ganglia of Immune Mice Against Reinfection with Herpes Simplex Virus Type 2

Milligan, G. N., Bernstein, D. I., & Bourne, N. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.12.6093 · Cited by 192 · see citing works

Dendritic Cells Internalize Vaccine Adjuvant after Intramuscular Injection

Dupuis, M., Murphy, T. J., Higgins, D., Ugozzoli, M., Nest, G. V., Ott, G. S., & McDonald, D. M. (1998) · Cellular Immunology · doi:10.1006/cimm.1998.1283 · Cited by 185 · see citing works

Clinical Reactivation of Genital Herpes Simplex Virus Infection Decreases in Frequency over Time

Benedetti, J., Zeh, J. E., & Corey, L. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-1-199907060-00004 · Cited by 181 · see citing works

ATAR, a Novel Tumor Necrosis Factor Receptor Family Member, Signals through TRAF2 and TRAF5

Hsu, H., Solovyev, I., Colombero, A. M., Elliott, R., Kelley, M. J., & Boyle, W. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.21.13471 · Cited by 180 · see citing works

A Recombinant Glycoprotein Vaccine for Herpes Simplex Type 2: Safety and Efficacy

Langenberg, A. G. M., Burke, R. L., Adair, S. F., et al. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-12-199506150-00001 · Cited by 179 · see citing works

Immature Monocyte-Derived Dendritic Cells Are Productively Infected with Herpes Simplex Virus Type 1

Mikloška, Z., Bosnjak, L., & Cunningham, A. L. (2001) · Journal of Virology · doi:10.1128/jvi.75.13.5958-5964.2001 · Cited by 179 · see citing works

A viral function represses accumulation of transcripts from productive-cycle genes in mouse ganglia latently infected with herpes simplex virus

Chen, S. H., Kramer, M. F., Schaffer, P. A., et al. (1997) · Journal of Virology · doi:10.1128/jvi.71.8.5878-5884.1997 · Cited by 178 · see citing works

Demonstration of Exogenous Genital Reinfection with Herpes Simplex Virus Type 2 by Restriction Endonuclease Fingerprinting of Viral DNA

Buchman, T. G., Roizman, B., & Nahmias, A. J. (1979) · The Journal of Infectious Diseases · doi:10.1093/infdis/140.3.295 · Cited by 175 · see citing works

Sorting out the new HSV type specific antibody tests

Ashley, R. L. (2001) · Sexually Transmitted Infections · doi:10.1136/sti.77.4.232 · Cited by 171 · see citing works

Immunotherapy of Recurrent Genital Herpes with Recombinant Herpes Simplex Virus Type 2 Glycoproteins D and B: Results of a Placebo‐Controlled Vaccine Trial

Straus, S. E., Wald, A., Kost, R. G., et al. (1997) · The Journal of Infectious Diseases · doi:10.1086/514103 · Cited by 169 · see citing works

Presence of Effector CD8+ T Cells in Hepatitis C Virus-Exposed Healthy Seronegative Donors

Scognamiglio, P., Accapezzato, D., Casciaro, M., Cacciani, A., Artini, M., Bruno, G., Chircu, M. L., Sidney, J., Southwood, S., Abrignani, S., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6681 · Cited by 163 · see citing works

The Probability of In Vivo Reactivation of Herpes Simplex Virus Type 1 Increases with the Number of Latently Infected Neurons in the Ganglia

Sawtell, N. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.8.6888-6892.1998 · Cited by 163 · see citing works

Erythema multiforme: Clinical, histopathologic, and immunologic study

Howland, W. W., Golttz, L. E., Weston, W. L., et al. (1984) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(84)80090-0 · Cited by 157 · see citing works

A Genetically Inactivated Herpes Simplex Virus Type 2 (HSV-2) Vaccine Provides Effective Protection against Primary and Recurrent HSV-2 Disease

Boursnell, M. E. G., Entwisle, C., Blakeley, D. M., et al. (1997) · The Journal of Infectious Diseases · doi:10.1093/infdis/175.1.16 · Cited by 157 · see citing works

Adjuvant Activities of Immune Response Modifier R-848: Comparison with CpG ODN

Vasilakos, J. P., Smith, R. M., Gibson, S. J., Lindh, J. M., Pederson, L. K., Reiter, M. J., Smith, M. H., & Tomai, M. A. (2000) · Cellular Immunology · doi:10.1006/cimm.2000.1689 · Cited by 155 · see citing works

In Vivo Behavior of Genetically Engineered Herpes Simplex Viruses R7017 and R7020. II. Studies in Immunocompetent and Immunosuppressed Owl Monkeys (Aotus trivirgatus)

Meignier, B., Martin, B., Whitley, R. J., et al. (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/162.2.313 · Cited by 155 · see citing works

In Vivo Modulation of Vaccine-Induced Immune Responses toward a Th1 Phenotype Increases Potency and Vaccine Effectiveness in a Herpes Simplex Virus Type 2 Mouse Model

Sin, J., Kim, J. J., Boyer, J., Ciccarelli, R. B., Higgins, T. J., & Weiner, D. B. (1999) · Journal of Virology · doi:10.1128/jvi.73.1.501-509.1999 · Cited by 154 · see citing works

Direct Recovery of Herpes Simplex Virus (HSV)-Specific T Lymphocyte Clones from Recurrent Genital HSV-2 Lesions

Koelle, D. M., Abbo, H., Peck, A., et al. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.5.956 · Cited by 152 · see citing works

Systemic cytokine profiles in BALB/c mice immunized with trivalent influenza vaccine containing MF59 oil emulsion and other advanced adjuvants.

Valensi, J. P., Carlson, J. R., & Nest, G. A. V. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.9.4029 · Cited by 146 · see citing works

Severe genital herpes infections in HIV-infected individuals with impaired herpes simplex virus-specific CD8 + cytotoxic T lymphocyte responses

Posavad, C. M., Koelle, D. M., Shaughnessy, M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10289 · Cited by 143 · see citing works

Human herpes simplex virus (HSV)-specific CD8+ CTL clones recognize HSV-2-infected fibroblasts after treatment with IFN-γ or when virion host shutoff functions are disabled

Tigges, M. A., Leng, S. X., Johnson, D. C., et al. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.10.3901 · Cited by 142 · see citing works

Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administration

Baldridge, J. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00572-1 · Cited by 136 · see citing works

Protective Vaccination Against Primary And Recurrent Disease Caused By Herpes Simplex Virus (HSV) Type 2 Using A Genetically Disabled HSV-1

McLean, C. S., Ertürk, M., Jennings, R., Challanáin, D. N., Minson, A. C., Duncan, I. A., Boursnell, M. E. G., & Inglis, S. C. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/170.5.1100 · Cited by 135 · see citing works

The Imidazoquinolines, Imiquimod and R-848, Induce Functional, but Not Phenotypic, Maturation of Human Epidermal Langerhans' Cells

Burns, R. P., Ferbel, B., Tomai, M. A., et al. (2000) · Clinical Immunology · doi:10.1006/clim.1999.4804 · Cited by 132 · see citing works

Double-Blind, Placebo-Controlled Trial of a Herpes Simplex Virus Type 2 Glycoprotein Vaccine in Persons at High Risk for Genital Herpes Infection

MERTZ, G. J., Ashley, R. L., Burke, R. L., et al. (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/161.4.653 · Cited by 131 · see citing works

Analysis of the relationship between viral infection and autoimmune disease.

Panoutsakopoulou, V., Sanchirico, M., Huster, K., Jansson, M., Granucci, F., Shim, D., Wucherpfennig, K., & Cantor, H. (2001) · Immunity · doi:10.1016/s1074-7613(01)00172-8 · Cited by 130 · see citing works

Herpes simplex virus vaccines

Bernstein, D. I., & Stanberry, L. R. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00434-4 · Cited by 129 · see citing works

In Vivo Immune Evasion Mediated by the Herpes Simplex Virus Type 1 Immunoglobulin G Fc Receptor

Nagashunmugam, T., Lubinski, J. M., Wang, L., Goldstein, L. T., Weeks, B. S., Sundaresan, P., Kang, E. H., Dubin, G. O., & Friedman, H. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.7.5351-5359.1998 · Cited by 129 · see citing works

Anterograde Transport of Herpes Simplex Virus Type 1 in Cultured, Dissociated Human and Rat Dorsal Root Ganglion Neurons

Saksena, M. M., Armati, P. J., Boadle, R. A., Holland, D. J., & Cunningham, A. L. (2000) · Journal of Virology · doi:10.1128/jvi.74.4.1827-1839.2000 · Cited by 128 · see citing works

Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions

Koelle, D. M., Corey, L., Burke, R. L., et al. (1994) · Journal of Virology · doi:10.1128/jvi.68.5.2803-2810.1994 · Cited by 127 · see citing works

A Null Mutation in the Gene Encoding the Herpes Simplex Virus Type 1 UL37 Polypeptide Abrogates Virus Maturation

Desai, P. J., Sexton, G. L., McCaffery, J. M., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.21.10259-10271.2001 · Cited by 126 · see citing works

Primary and Secondary Syphilis Lesions Contain mRNA for Thl Cytokines

Voorhis, W. C. V., Barrett, L. K., Koelle, D. M., et al. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.2.491 · Cited by 126 · see citing works

Risk of Acquisition of Genital Herpes Simplex Virus Type 2 in Sex Partners of Persons with Genital Herpes: A Prospective Couple Study

Bryson, Y. J., Dillon, M., Bernstein, D. I., et al. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.4.942 · Cited by 125 · see citing works

Herpes Simplex Virus Type 2 ICP47 Inhibits Human TAP but Not Mouse TAP

Tomazin, R., van Schoot, N. E. G., Goldsmith, K., Jugovic, P., Sempé, P., Früh, K., & Johnson, D. C. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2560-2563.1998 · Cited by 125 · see citing works

Dendritic Cell Maturation and Subsequent Enhanced T-Cell Stimulation Induced with the Novel Synthetic Immune Response Modifier R-848

Ahonen, C. L., Gibson, S. J., Smith, R. M., Pederson, L. K., Lindh, J. M., Tomai, M. A., & Vasilakos, J. P. (1999) · Cellular Immunology · doi:10.1006/cimm.1999.1555 · Cited by 123 · see citing works

In Vivo Role of Complement-Interacting Domains of Herpes Simplex Virus Type 1 Glycoprotein Gc

Lubinski, J. M., Wang, L., Mastellos, D. C., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.11.1637 · Cited by 123 · see citing works

HLA-DQ Tetramers Identify Epitope-Specific T Cells in Peripheral Blood of Herpes Simplex Virus Type 2-Infected Individuals: Direct Detection of Immunodominant Antigen-Responsive Cells

Kwok, W. W., Liu, A. W., Novak, E. J., Gebe, J. A., Ettinger, R. A., Nepom, G. T., Reymond, S. N., & Koelle, D. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4244 · Cited by 120 · see citing works

Alpha and Gamma Interferons Inhibit Herpes Simplex Virus Type 1 Infection and Spread in Epidermal Cells after Axonal Transmission

Mikloška, Z., & Cunningham, A. L. (2001) · Journal of Virology · doi:10.1128/jvi.75.23.11821-11826.2001 · Cited by 119 · see citing works

Monoclonal antibodies define a domain on herpes simplex virus glycoprotein B involved in virus penetration

Highlander, S. L., Cai, W., Person, S., et al. (1988) · Journal of Virology · doi:10.1128/jvi.62.6.1881-1888.1988 · Cited by 118 · see citing works

Immunization with a Single Major Histocompatibility Complex Class I-Restricted Cytotoxic T-Lymphocyte Recognition Epitope of Herpes Simplex Virus Type 2 Confers Protective Immunity

Blaney, J. E., Nobusawa, E., Brehm, M. A., et al. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.9567-9574.1998 · Cited by 117 · see citing works

CD8 CTL from Genital Herpes Simplex Lesions: Recognition of Viral Tegument and Immediate Early Proteins and Lysis of Infected Cutaneous Cells

Koelle, D. M., Chen, H. B., Gavin, M. A., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.4049 · Cited by 116 · see citing works

Herpes Simplex Virus Type 1 Infection of Activated Cytotoxic T Cells

Raftery, M., Behrens, C. K., Müller, A., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.8.1103 · Cited by 114 · see citing works

Microglia induce myelin basic protein-specific T cell anergy or T cell activation, according to their state of activation

Matyszak, M. K., Denis‐Donini, S., Citterio, S., Longhi, R., Granucci, F., & Ricciardi‐Castagnoli, P. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199910)29:10 · Cited by 114 · see citing works

Herpes Simplex Virus Associated Erythema Multiforme (HAEM) is Mechanistically Distinct from Drug-Induced Erythema Multiforme: Interferon-γ is Expressed in HAEM Lesions and Tumor Necrosis Factor-α in Drug-Induced Erythema Multiforme Lesions

Kokuba, H., Aurelian, L., & Burnett, J. W. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00754.x · Cited by 113 · see citing works

Herpes simplex virus antiviral drug resistance — current trends and future prospects

Field, H. J. (2001) · Journal of Clinical Virology · doi:10.1016/s1386-6532(00)00169-4 · Cited by 110 · see citing works

Resistance to herpes stromal keratitis conferred by an lgG2a-derived peptide

Avery, A. C., Zhao, Z.-S., Rodríguez-García, A., Bikoff, E. K., Soheilian, M., Foster, C. S., & Cantor, H. (1995) · Nature · doi:10.1038/376431a0 · Cited by 109 · see citing works

Mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: cytotoxic T cells

Martin, S. J., Moss, B. A., Berman, P. W., et al. (1987) · Journal of Virology · doi:10.1128/jvi.61.3.726-734.1987 · Cited by 108 · see citing works

Induction of Interferon-α by Glycoprotein D of Herpes Simplex Virus: A Possible Role of Chemokine Receptors

Ankel, H., Westra, D. F., Welling‐Wester, S., & Lebon, P. (1998) · Virology · doi:10.1006/viro.1998.9432 · Cited by 108 · see citing works

Detection of a Herpes Simplex Viral Antigen in Skin Lesions of Erythema Multiforme

Orton, P. W., HUFF, J. C., TONNESEN, M. G., et al. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-1-48 · Cited by 107 · see citing works

Construction, Phenotypic Analysis, and Immunogenicity of a UL5/UL29 Double Deletion Mutant of Herpes Simplex Virus 2

Costa, X. J. D., Kramer, M. F., Zhu, J., Brockman, M. A., & Knipe, D. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.17.7963-7971.2000 · Cited by 106 · see citing works

Detection of HSV-specific DNA in biopsy tissue of patients with erythema multiforme by polymerase chain reaction

Aslanzadeh, J., Helm, K. F., Espy, M. J., et al. (1992) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1992.tb08397.x · Cited by 103 · see citing works

Prime-Boost Immunization with DNA Vaccine: Mucosal Route of Administration Changes the Rules

Eo, S. K., Gieryńska, M. M., Abo-Kamar, A. M., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5473 · Cited by 103 · see citing works

A randomized, controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvant

Heineman, T. C. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00088-2 · Cited by 101 · see citing works

Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens

Tigges, M. A., Koelle, D. M., Hartog, K., et al. (1992) · Journal of Virology · doi:10.1128/jvi.66.3.1622-1634.1992 · Cited by 101 · see citing works

Application of a Topical Immune Response Modifier, Resiquimod Gel, to Modify the Recurrence Rate of Recurrent Genital Herpes: A Pilot Study

Spruance, S. L., Tyring, S. K., Smith, M. H., & Meng, T. (2001) · The Journal of Infectious Diseases · doi:10.1086/322007 · Cited by 99 · see citing works

Erythema Multiforme and Toxic Epidermal Necrolysis: A Comparative Study

Paquet, P., & Pierard, G. (1997) · American Journal of Dermatopathology · doi:10.1097/00000372-199704000-00005 · Cited by 97 · see citing works

gamma Interferon production appears to predict time of recurrence of herpes labialis.

Cunningham, A. L., & Merigan, T. C. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.5.2397 · Cited by 96 · see citing works

In Vivo Production of Cytokines and (C-C) Chemokines in Human Recurrent Herpes Simplex Lesions--Do Herpes Simplex Virus-Infected Keratinocytes Contribute to Their Production?

Miklos, Z., Danis, V. A., Adams, S., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/515236 · Cited by 96 · see citing works

Requirements for the Induction of Interleukin-6 by Herpes Simplex Virus-Infected Leukocytes

Paludan, S. (2001) · Journal of Virology · doi:10.1128/jvi.75.17.8008-8015.2001 · Cited by 96 · see citing works

Bystander Activation Involving T Lymphocytes in Herpetic Stromal Keratitis

Kaistha, S. D., Zheng, M., Lee, S., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2902 · Cited by 95 · see citing works

Seroprevalence and Incidence of Sexually Transmitted Diseases in a Rural Ugandan Population

Wagner, H. U., Dyck, E. V., Roggen, E., et al. (1994) · International Journal of STD & AIDS · doi:10.1177/095646249400500509 · Cited by 95 · see citing works

Incoming Human Cytomegalovirus pp65 (UL83) Contained in Apoptotic Infected Fibroblasts Is Cross-Presented to CD8+T Cells by Dendritic Cells

Arrode, G., Boccaccio, C., Lulé, J., Allart, S., Moinard, N., Abastado, J., Alam, A., & Davrinche, C. (2000) · Journal of Virology · doi:10.1128/jvi.74.21.10018-10024.2000 · Cited by 95 · see citing works

The gH-gL Complex of Herpes Simplex Virus (HSV) Stimulates Neutralizing Antibody and Protects Mice against HSV Type 1 Challenge

Peng, T., Ponce-de-León, M., Jiang, H., et al. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.65-72.1998 · Cited by 94 · see citing works

Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD.

Zarling, J. M., Moran, P. A., Burke, R. L., et al. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.12.4669 · Cited by 93 · see citing works

Human Cytomegalovirus pp65- and Immediate Early 1 Antigen-Specific HLA Class I-Restricted Cytotoxic T Cell Responses Induced by Cross-Presentation of Viral Antigens

Tabi, Z., Moutaftsi, M., & Borysiewicz, L. K. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5695 · Cited by 93 · see citing works

Tegument-Specific, Virus-Reactive CD4 T Cells Localize to the Cornea in Herpes Simplex Virus Interstitial Keratitis in Humans

Koelle, D. M., Reymond, S. N., Chen, H., Kwok, W. W., McClurkan, C. L., Gyaltsong, T., Petersdorf, E. W., Rotkis, W. M., Talley, A. R., & Harrison, D. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.23.10930-10938.2000 · Cited by 93 · see citing works

The role of the UL41 gene of herpes simplex virus type 1 in evasion of non-specific host defence mechanisms during primary infection

Suzutani, T., Nagamine, M., Shibaki, T., Ogasawara, M., Yoshida, I., Daikoku, T., Nishiyama, Y., & Azuma, M. (2000) · Microbiology · doi:10.1099/0022-1317-81-7-1763 · Cited by 93 · see citing works

Genetic Analysis of the Role of Herpes Simplex Virus Type 1 Glycoprotein K in Infectious Virus Production and Egress

Foster, T. P., & Kousoulas, K. G. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8457-8468.1999 · Cited by 92 · see citing works

Recognition of Herpes Simplex Virus Type 2 Tegument Proteins by CD4 T Cells Infiltrating Human Genital Herpes Lesions

Koelle, D. M., Frank, J. M., Johnson, M., et al. (1998) · Journal of Virology · doi:10.1128/jvi.72.9.7476-7483.1998 · Cited by 92 · see citing works

Anterograde Transport of Herpes Simplex Virus Proteins in Axons of Peripheral Human Fetal Neurons: an Immunoelectron Microscopy Study

Holland, D. J., Saksena, M. M., Boadle, R. A., Armati, P. J., & Cunningham, A. L. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8503-8511.1999 · Cited by 91 · see citing works

New developments in the epidemiology, natural history and management of genital herpes

Stanberry, L. R., Cunningham, A. L., MERTZ, G. J., Mindel, A., PETERS, B., Reitano, M. V., Sacks, S. H., Wald, A., Wassilew, S. W., & Woolley, P. D. (1999) · Antiviral Research · doi:10.1016/s0166-3542(99)00004-2 · Cited by 91 · see citing works

Evidence of Latency and Reactivation of Both Herpes Simplex Virus (HSV)‐1 and HSV‐2 in the Genital Region

Sucato, G. S., Wald, A., Wakabayashi, E., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/515261 · Cited by 91 · see citing works

Mucosal Immunity to Herpes Simplex Virus Type 2 Infection in the Mouse Vagina Is Impaired by In Vivo Depletion of T Lymphocytes

Parr, M. B., & Parr, E. L. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.2677-2685.1998 · Cited by 91 · see citing works

The Major Neutralizing Antigenic Site on Herpes Simplex Virus Glycoprotein D Overlaps a Receptor-Binding Domain

Whitbeck, J. C., Muggeridge, M. I., Rux, A. H., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.12.9879-9890.1999 · Cited by 90 · see citing works

Presence of VZV and HSV-1 DNA in Human Nodose and Celiac Ganglia

Gilden, D. H., Gesser, R., Smith, J., Wellish, M., LaGuardia, J. J., Cohrs, R. J., & Mahalingam, R. (2001) · Virus Genes · doi:10.1023/a:1011883919058 · Cited by 88 · see citing works

Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes.

Mikloška, Z., & Cunningham, A. L. (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-2-353 · Cited by 88 · see citing works

High frequency of CD8+ cytotoxic T-lymphocyte precursors specific for herpes simplex viruses in persons with genital herpes

Posavad, C. M., Koelle, D. M., & Corey, L. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.8165-8168.1996 · Cited by 88 · see citing works

Role of Mucosal Immunity in Herpes Simplex Virus Infection

Kuklin, N. A., Daheshia, M., Chun, S., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.12.5998 · Cited by 87 · see citing works

Humoral immune response to HSV‐1 and HSV‐2 viral proteins in patients with primary genital herpes

Ashley, R. L., Benedetti, J., & Corey, L. (1985) · Journal of Medical Virology · doi:10.1002/jmv.1890170208 · Cited by 85 · see citing works

Immunization against genital herpes with a vaccine virus that has defects in productive and latent infection

Costa, X. J. D., Jones, C., & Knipe, D. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6994 · Cited by 84 · see citing works

Herpes simplex virus infection of human fibroblasts and keratinocytes inhibits recognition by cloned CD8+ cytotoxic T lymphocytes.

Koelle, D. M., Tigges, M. A., Burke, R. L., et al. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116317 · Cited by 84 · see citing works

Herpes Simplex Virus-Induced Keratitis: Evaluation of the Role of Molecular Mimicry in Lesion Pathogenesis

Kaistha, S. D., Lee, S., Zheng, M., Song, B., Knipe, D. M., Kapp, J. A., & Rouse, B. T. (2001) · Journal of Virology · doi:10.1128/jvi.75.7.3077-3088.2001 · Cited by 84 · see citing works

Oral acyclovir for the prevention of herpes-associated erythema multiforme

Lemak, M. A., Duvic, M., & Bean, S. F. (1986) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(86)70141-2 · Cited by 83 · see citing works

Construction and Characterization of a Replication-Defective Herpes Simplex Virus 2 ICP8 Mutant Strain and Its Use in Immunization Studies in a Guinea Pig Model of Genital Disease

Costa, X. J. D., Bourne, N., Stanberry, L. R., et al. (1997) · Virology · doi:10.1006/viro.1997.8564 · Cited by 82 · see citing works

Modulation of Immunity against Herpes Simplex Virus Infection via Mucosal Genetic Transfer of Plasmid DNA Encoding Chemokines

Eo, S. K., Lee, S., Chun, S., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.2.569-578.2001 · Cited by 82 · see citing works

Herpes Simplex Virus Protein Targets for CD4 and CD8 Lymphocyte Cytotoxicity in Cultured Epidermal Keratinocytes Treated with Interferon-γ

Mikloška, Z., Kesson, A. M., Penfold, M. E. T., et al. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.1.7 · Cited by 82 · see citing works

Molecular Mechanisms of B Lymphocyte Activation by the Immune Response Modifier R-848

Bishop, G. A., Hsing, Y., Hostager, B. S., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5552 · Cited by 82 · see citing works

IL-1 and TNF-alpha are important factors in the pathogenesis of murine recurrent herpetic stromal keratitis.

Keadle, T. L., Usui, N., Laycock, K. A., et al. (2000) · PubMed · Cited by 81 · see citing works

Replication-defective mutants of herpes simplex virus (HSV) induce cellular immunity and protect against lethal HSV infection

Nguyen, L., Knipe, D. M., & Finberg, R. W. (1992) · Journal of Virology · doi:10.1128/jvi.66.12.7067-7072.1992 · Cited by 81 · see citing works

Granzyme A, a Noncytolytic Component of CD8+Cell Granules, Restricts the Spread of Herpes Simplex Virus in the Peripheral Nervous Systems of Experimentally Infected Mice

Pereira, R. A., Simon, M. M., & Simmons, A. (2000) · Journal of Virology · doi:10.1128/jvi.74.2.1029-1032.2000 · Cited by 80 · see citing works

Vaccination with recombinant vaccinia viruses expressing ICP27 induces protective immunity against herpes simplex virus through CD4+ Th1+ T cells

Manickan, E., Francotte, M., Kuklin, N. A., et al. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.4711-4716.1995 · Cited by 78 · see citing works

Herpes simplex virus type I infection of the CNS induces major histocompatibility complex antigen expression on rat microglia

Weinstein, D. L., Walker, D. G., Akiyama, H., & McGeer, P. L. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490260107 · Cited by 77 · see citing works

Erythema multiforme lesions are associated with expression of a herpes simplex virus (HSV) gene and qualitative alterations in the HSV-specific T-cell response

Kokuba, Imafuku, Huang, et al. (1998) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1998.02260.x · Cited by 76 · see citing works

Detection of Viral DNA Within Skin of Healed Recurrent Herpes Simplex Infection and Erythema Multiforme Lesions

Miura, S., Smith, C. C., Burnett, J. W., et al. (1992) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12495372 · Cited by 76 · see citing works

A prophylactic hepatitis B vaccine with a novel adjuvant system

Thoelen, S., Clercq, N. D., & Tornieporth, N. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00462-x · Cited by 74 · see citing works

The Quantity of Latent Viral DNA Correlates with the Relative Rates at Which Herpes Simplex Virus Types 1 and 2 Cause Recurrent Genital Herpes Outbreaks

Lekstrom-Himes, J. A., Pesnicak, L., & Straus, S. E. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.2760-2764.1998 · Cited by 73 · see citing works

Neutralizing Antibodies Inhibit Axonal Spread of Herpes Simplex Virus Type 1 to Epidermal Cells In Vitro

Mikloška, Z., Sanna, P. P., & Cunningham, A. L. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.5934-5944.1999 · Cited by 73 · see citing works

Persistent Elevated Expression of Cytokine Transcripts in Ganglia Latently Infected with Herpes Simplex Virus in the Absence of Ganglionic Replication or Reactivation

Chen, S., Garber, D. A., Schaffer, P. A., et al. (2000) · Virology · doi:10.1006/viro.2000.0643 · Cited by 72 · see citing works

Mechanisms of Immunization with a Replication-Defective Mutant of Herpes Simplex Virus 1

Morrison, L. A., & Knipe, D. M. (1996) · Virology · doi:10.1006/viro.1996.0328 · Cited by 72 · see citing works

Evaluation of a Live Attenuated Recombinant Virus RAV 9395 as a Herpes Simplex Virus Type 2 Vaccine in Guinea Pigs

Spector, F., Kern, E. R., Palmer, J., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/515278 · Cited by 71 · see citing works

Cutting Edge: A NK Complex-Linked Locus Governs Acute Versus Latent Herpes Simplex Virus Infection of Neurons

Pereira, R. A., Scalzo, A. A., & Simmons, A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.10.5869 · Cited by 70 · see citing works

Difference in Incidence of Spontaneous Mutations between Herpes Simplex Virus Types 1 and 2

Sarisky, R. T., Nguyen, T., Duffy, K. E., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1524-1529.2000 · Cited by 68 · see citing works

Chronic Vulvar Ulceration in an Immunocompetent Woman Due to Acyclovir‐Resistant, Thymidine Kinase‐Deficient Herpes Simplex Virus

Swetter, S. M., Hill, E. L., Kern, E. R., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/514229 · Cited by 68 · see citing works

Novel Mechanism of Antibody-Independent Complement Neutralization of Herpes Simplex Virus Type 1

Friedman, H. M., Wang, L., Pangburn, M. K., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.8.4528 · Cited by 67 · see citing works

Prevalence of herpes simplex virus types 1 and 2, cytomegalovirus, and varicella-zoster virus infections in Eritrea

Ghebrekidan, H., Rudén, U., Cox, S. W., et al. (1999) · Journal of Clinical Virology · doi:10.1016/s0928-0197(98)00064-6 · Cited by 67 · see citing works

Fas-Independent Cytotoxicity Mediated by Human CD4+ CTL Directed Against Herpes Simplex Virus-Infected Cells

Yasukawa, M., Ohminami, H., Yakushijin, Y., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.10.6100 · Cited by 67 · see citing works

Monophosphoryl Lipid A and QS21 Increase CD8 T Lymphocyte Cytotoxicity to Herpes Simplex Virus-2 Infected Cell Proteins 4 and 27 Through IFN-γ and IL-12 Production

Mikloška, Z., Rückholdt, M., Ghadiminejad, I., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.5167 · Cited by 66 · see citing works

Multi-attenuated herpes simplex virus-1 mutant G207 exerts cytotoxicity against epithelial ovarian cancer but not normal mesothelium and is suitable for intraperitoneal oncolytic therapy

Coukos, G., Makrigiannakis, A., Montas, S., et al. (2000) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700130 · Cited by 66 · see citing works

Transcription from the Gene Encoding the Herpesvirus Entry Receptor Nectin-1 (HveC) in Nervous Tissue of Adult Mouse

Haarr, L., Shukla, D., Rødahl, E., Canto, M. C. D., & Spear, P. G. (2001) · Virology · doi:10.1006/viro.2001.1041 · Cited by 65 · see citing works

Herpes simplex virus-specific T cells infiltrate the cornea of patients with herpetic stromal keratitis: no evidence for autoreactive T cells.

Verjans, G. M. G. M., Remeijer, L., Mooy, C. M., et al. (2000) · PubMed · Cited by 65 · see citing works

The yeast cell wall, a dynamic structure engaged in growth and morphogenesis

Cabib, E., Drgon, T., Drgonová, J., Ford, R. A., & KOLLÁR, R. (1997) · Biochemical Society Transactions · doi:10.1042/bst0250200 · Cited by 65 · see citing works

Herpes Simplex Viremia: Report of Eight Pediatric Cases and Review of the Literature

Stanberry, L. R., Floyd-Reising, S. A., Connelly, B. L., Alter, S. J., Gilchrist, M. J. R., Rubio, C., & Myers, M. G. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.3.401 · Cited by 64 · see citing works

Significance of Local Interferon in Recurrent Herpes Simplex Infection

Torseth, J. W., & Merigan, T. C. (1986) · The Journal of Infectious Diseases · doi:10.1093/infdis/153.5.979 · Cited by 64 · see citing works

Role as Antibody-Dependent Cellular Cytotoxicity in Defense Against Herpes Simplex Virus Infections

Kohl, S. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/13.1.108 · Cited by 63 · see citing works

Role of keratinocytes in human recurrent herpetic lesions. Ability to present herpes simplex virus antigen and act as targets for T lymphocyte cytotoxicity in vitro.

Cunningham, A. L., & Noble, J. R. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113908 · Cited by 63 · see citing works

Immunopotentiation of DNA vaccine against herpes simplex virus via co-delivery of plasmid DNA expressing CCR7 ligands

Eo, S. K., Lee, S., Kumaraguru, U., et al. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00241-9 · Cited by 63 · see citing works

Protein-Specific Cervical Antibody Responses to Primary Genital Herpes Simplex Virus Type 2 Infections

Ashley, R. L., Corey, L., Dalessio, J., et al. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/170.1.20 · Cited by 62 · see citing works

Herpes simplex virus thymidine kinase and specific stages of latency in murine trigeminal ganglia

Jacobson, J. G., Ruffner, K. L., Kosz‐Vnenchak, M., et al. (1993) · Journal of Virology · doi:10.1128/jvi.67.11.6903-6908.1993 · Cited by 61 · see citing works

Acyclovir Blocks Cytokine Gene Expression in Trigeminal Ganglia Latently Infected with Herpes Simplex Virus Type 1

Halford, W. P., Gebhardt, B. M., & Carr, D. J. J. (1997) · Virology · doi:10.1006/viro.1997.8806 · Cited by 61 · see citing works

A Salmonella typhimurium htrA live vaccine expressing multiple copies of a peptide comprising amino acids 8–23 of herpes simplex virus glycoprotein D as a genetic fusion to tetanus toxin fragment C protects mice from herpes simplex virus infection

Chabalgoity, J. A., Khan, C. M. A., Nash, A. A., et al. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.426965.x · Cited by 61 · see citing works

Induction of a protective immune response by mucosal vaccination with a DISC HSV-1 vaccine

McLean, C. S., NíChallanáin, D., Duncan, I. A., et al. (1996) · Vaccine · doi:10.1016/0264-410x(95)00259-4 · Cited by 61 · see citing works

Identification and Characterization of Herpes Simplex Virus‐Specific CD4+T Cells in Corneas of Herpetic Stromal Keratitis Patients

Verjans, G. M. G. M., Remeijer, L., van Binnendijk, R. S., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/517382 · Cited by 61 · see citing works

Structural Features of Nectin-2 (HveB) Required for Herpes Simplex Virus Entry

Martinez, W. M., & Spear, P. G. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.11185-11195.2001 · Cited by 61 · see citing works

Leu-3+ T cells produce gamma-interferon in patients with recurrent herpes labialis.

Cunningham, A. L., & Merigan, T. C. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.132.1.197 · Cited by 60 · see citing works

The Influence Of Adjuvant On The Therapeutic Efficacy Of A Recombinant Genital Herpes Vaccine

Burke, R. L., Goldbeck, C., Ng, P., et al. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/170.5.1110 · Cited by 60 · see citing works

Induction and Enhancement of Immune Responses to Herpes Simplex Virus Type 2 in Humans by Use of a Recombinant Glycoprotein D Vaccine

Straus, S. E., Savarese, B., Tigges, M. A., et al. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1045 · Cited by 59 · see citing works

Cell Surface Expression of H2 Antigens on Primary Sensory Neurons in Response to Acute but Not Latent Herpes Simplex Virus Infection In Vivo

Pereira, R. A., & Simmons, A. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6484-6489.1999 · Cited by 59 · see citing works

The in situ cellular immune response in acute herpes simplex encephalitis.

Sobel, R. A., Collins, A. B., Colvin, R. B., & Bhan, A. K. (1986) · PubMed Central · Cited by 58 · see citing works

Viral Vector Systems for Gene Therapy: A Comprehensive Literature Review of Progress and Biosafety Challenges

Ghosh, S., Brown, A. M., Jenkins, C., & Campbell, K. (2020) · Applied Biosafety · doi:10.1177/1535676019899502 · Cited by 218 · see citing works

The Acquired Immune System

Hedrick, S. M. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.020 · Cited by 122 · see citing works

Sustained elevation of kynurenic Acid in the cerebrospinal fluid of patients with herpes simplex virus type 1 encephalitis

Atlas, A., Franzen-Röhl, E., Söderlund, J., Jönsson, E. G., Samuelsson, M., Schwieler, L., Sköldenberg, B., & Engberg, G. (2013) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s13256 · Cited by 25 · see citing works

ИСПОЛЬЗОВAНИЕ ПОТЕНЦИAЛA СОЦИAЛЬНЫХ ПAРТНЕРОВ В ПОДГОТОВКЕ БУДУЩИХ ПЕДAГОГОВ

Атабекова, Б. Б. (2024) · Habaršy. Pedagogika ġylymdary seriâsy · doi:10.51889/2959-5762.2023.80.4.019

Cloning and Characterization of Rat BAT3 cDNA

Ozaki, T., Hanaoka, E., Naka, M., et al. (1999) · DNA and Cell Biology · doi:10.1089/104454999315222 · Cited by 22 · see citing works

EFFECT OF THE NEMATODE PHASMARHABDITIS HERMAPHRODITA ON YOUNG STAGES OF THE PEST SLUG ARION LUSITANICUS

Grimm, B. (2002) · Journal of Molluscan Studies · doi:10.1093/mollus/68.1.25 · Cited by 41 · see citing works

Herpes simplex virus latency in a hyperresistant clone of mouse neuroblastoma (Cl300) cells

Nilheden, E., Jeansson, S. L., & Vahlne, A. G. (1985) · Archives of Virology · doi:10.1007/bf01309927 · Cited by 21 · see citing works

The Virulence of West Nile Virus and TP 21 Virus and Their Application to a Group B Arbor Virus Vaccine

Price, W. H., Lee, R. W., Gunkel, W. F., et al. (1961) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1961.10.403 · Cited by 15 · see citing works